Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 112
- +19 vs. Q1 2021
- Portfolio value
- $3.70B
- +$115.8M (+3.2%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VRTXVertex Pharmaceuticals Inc | Stock | 950,000 | $191.5M | 5.2% | +639,100+205.6% | Added | History |
| ABBVAbbVie Inc. | Stock | 1,484,400 | $167.2M | 4.5% | −592,800−28.5% | Reduced | History |
| ARVNArvinas, Inc. | COM | 1,854,000 | $142.8M | 3.9% | +93,700+5.3% | Added | History |
| LLYEli Lilly & Co | Stock | 565,500 | $129.8M | 3.5% | +565,500 | New | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 2,963,545 | $123.7M | 3.3% | +202,000+7.3% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 753,000 | $121.6M | 3.3% | +277,300+58.3% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 2,160,000 | $114.9M | 3.1% | +896,700+71.0% | Added | History |
| AVTRAvantor, Inc. | COM | 3,180,000 | $112.9M | 3.1% | −1,805,100−36.2% | Reduced | History |
| SGENSeagen Inc. | COM | 640,000 | $101.0M | 2.7% | +62,100+10.7% | Added | History |
| BHVNBiohaven Ltd. | COM | 882,500 | $85.7M | 2.3% | −167,300−15.9% | Reduced | History |
| HOLXHologic Inc | COM | 1,208,800 | $80.7M | 2.2% | +1,208,800 | New | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 4,615,000 | $79.2M | 2.1% | +769,000+20.0% | Added | History |
| EPIXESSA Pharma Inc. | COM NEW | 2,750,000 | $78.6M | 2.1% | −90,000−3.2% | Reduced | History |
| EXASExact Sciences Corp | COM | 590,000 | $73.3M | 2.0% | −8,000−1.3% | Reduced | History |
| MDTMedtronic plc | Stock | 535,000 | $66.4M | 1.8% | −489,200−47.8% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 681,000 | $66.3M | 1.8% | +159,600+30.6% | Added | History |
| NUVBNuvation Bio Inc. | COM CL A | 6,966,376 | $64.9M | 1.8% | −555,565−7.4% | Reduced | History |
| ARNAArena Pharmaceuticals Inc | COM NEW | 943,000 | $64.3M | 1.7% | +44,450+4.9% | Added | History |
| BIIBBiogen Inc. | COM | 183,900 | $63.7M | 1.7% | +183,900 | New | History |
| NEONeogenomics Inc | COM NEW | 1,367,000 | $61.7M | 1.7% | +1,367,000 | New | History |
| NTLAIntellia Therapeutics, Inc. | COM | 380,000 | $61.5M | 1.7% | +380,000 | New | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 729,000 | $61.2M | 1.7% | −600,000−45.1% | Reduced | History |
| CTLTCatalent, Inc. | COM | 540,000 | $58.4M | 1.6% | −20,000−3.6% | Reduced | History |
| STTKShattuck Labs, Inc. | COM | 1,940,200 | $56.2M | 1.5% | +609,815+45.8% | Added | History |
| CNCCentene Corp | Stock | 751,200 | $54.8M | 1.5% | +751,200 | New | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 568,000 | $53.2M | 1.4% | −13,000−2.2% | Reduced | History |
| BPMCBlueprint Medicines Corp | COM | 563,200 | $49.5M | 1.3% | +17,200+3.2% | Added | History |
| NTRANatera, Inc. | COM | 436,000 | $49.5M | 1.3% | +40,400+10.2% | Added | History |
| SHCSotera Health Co | COM | 1,910,000 | $46.3M | 1.3% | +749,000+64.5% | Added | History |
| XLRNAcceleron Pharma Inc | COM | 358,500 | $45.0M | 1.2% | +35,700+11.1% | Added | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,070,000 | $43.4M | 1.2% | +598,000+40.6% | Added | History |
| UTHRUnited Therapeutics Corp | COM | 236,400 | $42.4M | 1.1% | +236,400 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 673,400 | $41.0M | 1.1% | −141,700−17.4% | Reduced | History |
| ATECAlphatec Holdings, Inc. | COM NEW | 2,621,000 | $40.2M | 1.1% | +287,000+12.3% | Added | History |
| Trillium Therapeutics Inc.89620X506 | COM NEW | 4,105,000 | $39.8M | 1.1% | +90,000+2.2% | Added | – |
| CYTCyteir Therapeutics, Inc. | COM | 1,808,394 | $38.7M | 1.0% | +1,808,394 | New | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,000,000 | $38.1M | 1.0% | +1,000,000 | New | History |
| CAHCardinal Health Inc | Stock | 654,200 | $37.3M | 1.0% | −808,800−55.3% | Reduced | History |
| KDMNKadmon Holdings, Inc. | COM | 9,294,600 | $36.0M | 1.0% | −249,600−2.6% | Reduced | History |
| DVAXDynavax Technologies Corp | COM NEW | 3,400,000 | $33.5M | 0.9% | −100,000−2.9% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 195,000 | $33.1M | 0.9% | −232,969−54.4% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 1,150,050 | $32.7M | 0.9% | +1,150,050 | New | History |
| SPNESeaSpine Holdings Corp | COM | 1,524,998 | $31.3M | 0.8% | +1,524,998 | New | History |
| LFSTLifeStance Health Group, Inc. | COM | 1,100,000 | $30.6M | 0.8% | +1,100,000 | New | History |
| IPSCCentury Therapeutics, Inc. | COM | 1,003,522 | $29.4M | 0.8% | +1,003,522 | New | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 625,000 | $25.7M | 0.7% | +625,000 | New | History |
| IMCRImmunocore Holdings plc | ADS | 601,000 | $23.5M | 0.6% | +51,000+9.3% | Added | History |
| ACETAdicet Bio, Inc. | COM | 2,250,500 | $23.2M | 0.6% | +20,500+0.9% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 940,000 | $22.9M | 0.6% | +940,000 | New | History |
| LENZLENZ Therapeutics, Inc. | COM | 735,500 | $22.6M | 0.6% | +735,500 | New | History |
| HARPHarpoon Therapeutics, Inc. | COM | 1,500,000 | $20.8M | 0.6% | +92,000+6.5% | Added | History |
| PATHUiPath, Inc. | Stock | 300,000 | $20.4M | 0.6% | +300,000 | New | History |
| GRTSGritstone bio, Inc. | COM | 2,122,064 | $19.4M | 0.5% | 00.0% | Unchanged | History |
| SIBNSI-BONE, Inc. | COM | 575,000 | $18.1M | 0.5% | −2,570−0.4% | Reduced | History |
| ZLABZai Lab Ltd | ADR | 100,000 | $17.7M | 0.5% | +100,000 | New | History |
| ORTXOrchard Therapeutics plc | ADS | 3,781,798 | $16.6M | 0.4% | −536,002−12.4% | Reduced | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 1,450,000 | $16.4M | 0.4% | −1,102,000−43.2% | Reduced | History |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,315,000 | $16.1M | 0.4% | +30,000+0.7% | Added | History |
| SYNHSyneos Health, Inc. | CL A | 175,000 | $15.7M | 0.4% | +175,000 | New | History |
| SANASana Biotechnology, Inc. | COM | 778,597 | $15.3M | 0.4% | +46,276+6.3% | Added | History |
| SCYXScynexis Inc | COM NEW | 2,060,000 | $15.2M | 0.4% | +796,231+63.0% | Added | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,495,000 | $13.5M | 0.4% | −16,000−1.1% | Reduced | History |
| Bellus Health Inc New07987C204 | COM NEW | 4,250,000 | $13.2M | 0.4% | −2,547,400−37.5% | Reduced | – |
| ACIUAC Immune SA | SHS | 1,584,000 | $12.6M | 0.3% | +1,584,000 | New | History |
| GHRSGH Research PLC | ORDINARY SHARES | 560,000 | $12.2M | 0.3% | +560,000 | New | History |
| NAUTNautilus Biotechnology, Inc. | COM | 1,125,000 | $11.4M | 0.3% | +1,125,000 | New | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 650,265 | $11.3M | 0.3% | +650,265 | New | History |
| ZETAZeta Global Holdings Corp. | CL A | 1,300,000 | $10.9M | 0.3% | +1,300,000 | New | History |
| CMAXCareMax, Inc. | COM CL A | 817,402 | $10.5M | 0.3% | +817,402 | New | History |
| PRTAProthena Corp Public Ltd Co | SHS | 182,000 | $9.36M | 0.3% | +182,000 | New | History |
| CRDFCardiff Oncology, Inc. | COM | 1,395,000 | $9.28M | 0.3% | −1,052,700−43.0% | Reduced | History |
| MNDYmonday.com Ltd. | SHS | 40,000 | $8.94M | 0.2% | +40,000 | New | History |
| ISEEIVERIC bio, Inc. | COM | 1,400,010 | $8.83M | 0.2% | +1,400,010 | New | History |
| DOCSDoximity, Inc. | CL A | 150,000 | $8.73M | 0.2% | +150,000 | New | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 104,000 | $8.61M | 0.2% | +104,000 | New | History |
| SSentinelOne, Inc. | CL A | 200,000 | $8.50M | 0.2% | +200,000 | New | History |
| ESPREsperion Therapeutics, Inc. | COM | 400,000 | $8.46M | 0.2% | +400,000 | New | History |
| ONCSOncosec Medical Inc | COM | 2,800,000 | $7.87M | 0.2% | −670,000−19.3% | Reduced | History |
| TILInstil Bio, Inc. | COM | 400,000 | $7.73M | 0.2% | 00.0% | Unchanged | History |
| VIRVir Biotechnology, Inc. | COM | 162,000 | $7.66M | 0.2% | +162,000 | New | History |
| PHVSPharvaris N.V. | COM | 400,000 | $7.45M | 0.2% | 00.0% | Unchanged | History |
| CM Life Sciences Inc18978W109 | COM CL A | 525,000 | $7.36M | 0.2% | −25,000−4.5% | Reduced | – |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 300,000 | $6.81M | 0.2% | +300,000 | New | History |
| DNLIDenali Therapeutics Inc. | COM | 86,100 | $6.75M | 0.2% | +86,100 | New | History |
| ATAIAtai Beckley N.V. | SHS | 350,987 | $6.49M | 0.2% | +350,987 | New | History |
| TRMLTourmaline Bio, Inc. | COM | 436,363 | $6.41M | 0.2% | +436,363 | New | History |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $5.36M | 0.1% | 00.0% | Unchanged | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $5.26M | 0.1% | 00.0% | Unchanged | – |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $5.02M | 0.1% | +520,000 | New | – |
| FIGSFIGS, Inc. | CL A | 100,000 | $5.01M | 0.1% | +100,000 | New | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $5.01M | 0.1% | +500,000 | New | – |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 500,000 | $4.97M | 0.1% | +500,000 | New | – |
| HYPRHyperfine, Inc. | CL A SHS | 500,000 | $4.92M | 0.1% | 00.0% | Unchanged | History |
| CELCCelcuity Inc. | COM | 200,000 | $4.80M | 0.1% | +200,000 | New | History |
| CFLTConfluent, Inc. | CLASS A COM | 100,000 | $4.75M | 0.1% | +100,000 | New | History |
| CM Life Sciences II Inc125842203 | UNIT 02/25/2028 | 330,000 | $4.44M | 0.1% | −6,700−2.0% | Reduced | – |
| Walkme LtdM97628107 | ORD SHS | 150,000 | $4.39M | 0.1% | +150,000 | New | – |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $4.14M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $4.08M | 0.1% | 00.0% | Unchanged | History |
| SNCEScience 37 Holdings, Inc. | COM | 400,000 | $4.00M | 0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (35)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| AZNAstraZeneca PLC | SPONSORED ADR | 3,650,500 | $181.5M | 5.1% | History |
| ISRGIntuitive Surgical Inc | COM NEW | 139,400 | $103.0M | 2.9% | History |
| BHCBausch Health Companies Inc. | Stock | 1,891,300 | $60.0M | 1.7% | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 326,000 | $52.2M | 1.5% | History |
| ChemoCentryx, Inc.16383L106 | COM | 940,800 | $48.2M | 1.3% | – |
| ABMDAbiomed Inc | COM | 132,500 | $42.2M | 1.2% | History |
| INOInovio Pharmaceuticals, Inc. | COM NEW | 4,004,391 | $37.2M | 1.0% | History |
| CICigna Group | Stock | 135,000 | $32.6M | 0.9% | History |
| LONALeonaBio, Inc. | COM | 1,677,845 | $30.9M | 0.9% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 707,359 | $29.5M | 0.8% | History |
| ORGOOrganogenesis Holdings Inc. | COM | 1,463,403 | $26.7M | 0.7% | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 1,330,700 | $24.6M | 0.7% | History |
| CRISCuris Inc | COM NEW | 2,053,789 | $23.2M | 0.6% | History |
| AUPHAurinia Pharmaceuticals Inc. | COM | 1,784,000 | $23.2M | 0.6% | History |
| IGMSIGM Biosciences, Inc. | COM | 293,000 | $22.5M | 0.6% | History |
| BOLTBolt Biotherapeutics, Inc. | COM | 654,294 | $21.5M | 0.6% | History |
| CMRXChimerix Inc | COM | 2,230,000 | $21.5M | 0.6% | History |
| BVSBioventus Inc. | COM CL A | 1,254,333 | $19.2M | 0.5% | History |
| SGTXSigilon Therapeutics, Inc. | COM | 850,968 | $19.0M | 0.5% | History |
| COLLCollegium Pharmaceutical, Inc | COM | 740,000 | $17.5M | 0.5% | History |
| KZRKezar Life Sciences, Inc. | COM | 1,907,081 | $11.4M | 0.3% | History |
| ADMSAdamas Pharmaceuticals Inc | COM | 2,200,200 | $10.6M | 0.3% | History |
| Affimed N VN01045108 | COM | 1,296,000 | $10.3M | 0.3% | – |
| MRUSMerus N.V. | COM | 487,000 | $10.2M | 0.3% | History |
| IMTXImmatics N.V. | SHS | 884,600 | $9.92M | 0.3% | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 400,000 | $8.80M | 0.2% | History |
| EVLOEvelo Biosciences, Inc. | COM | 800,000 | $8.56M | 0.2% | History |
| Vesper Healthcare Acqstn Cor92538T203 | UNIT 99/99/9999 | 600,000 | $6.93M | 0.2% | – |
| Arya Sciences Acquisition CoG3166W106 | COM CL A | 500,000 | $6.89M | 0.2% | – |
| ARGXArgenx SE | SPONSORED ADR | 20,000 | $5.51M | 0.2% | History |
| Medicus Sciences AcquisitionG5960S116 | UNIT 99/99/9999 | 520,000 | $5.12M | 0.1% | – |
| COGTCogent Biosciences, Inc. | COM | 417,710 | $3.67M | 0.1% | History |
| EYPTEyePoint, Inc. | COM NEW | 232,504 | $2.36M | 0.1% | History |
| ANNXAnnexon, Inc. | COM | 70,000 | $1.95M | 0.1% | History |
| AMWLAmerican Well Corp | CL A | 70,250 | $1.22M | <0.1% | History |